104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmn SYNOPSIS AS INTRODUCED: 215 ILCS 200/52 new Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude. LRB104 08130 BAB 18176 b A BILL FOR 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmn SYNOPSIS AS INTRODUCED: 215 ILCS 200/52 new 215 ILCS 200/52 new Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude. LRB104 08130 BAB 18176 b LRB104 08130 BAB 18176 b A BILL FOR
104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmn SYNOPSIS AS INTRODUCED:
215 ILCS 200/52 new 215 ILCS 200/52 new
215 ILCS 200/52 new
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.
LRB104 08130 BAB 18176 b LRB104 08130 BAB 18176 b
LRB104 08130 BAB 18176 b
A BILL FOR
SB1258LRB104 08130 BAB 18176 b SB1258 LRB104 08130 BAB 18176 b
SB1258 LRB104 08130 BAB 18176 b
1 AN ACT concerning regulation.
2 Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
4 Section 5. The Prior Authorization Reform Act is amended
5 by adding Section 52 as follows:
104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmn SYNOPSIS AS INTRODUCED:
215 ILCS 200/52 new 215 ILCS 200/52 new
215 ILCS 200/52 new
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.
LRB104 08130 BAB 18176 b LRB104 08130 BAB 18176 b
LRB104 08130 BAB 18176 b
A BILL FOR
215 ILCS 200/52 new
LRB104 08130 BAB 18176 b
SB1258 LRB104 08130 BAB 18176 b